Macular Degeneration Support -
Research
From new drug therapies to micro-telescopic
implants, macular degeneration is the subject of
vigorous research.
Age Related Macular Degeneration (ARMD) leads to
visual impairment and, in some cases, significant
central vision loss in millions of people.
Over the
last few years, there has been a strong increase in
awareness among researchers, the federal government
and private pharmaceutical companies as to the
magnitude of this problem. This has led to
significant economic resources being focused on this
problem, resulting in new and innovative therapies.
While new lasering techniques and
pharmaceuticals
are exciting, there are also significant preventive
steps that patients themselves can take in order to
reduce the risk of ARMD. Click on the links to the
right to learn more.
|
